21-hydroxylase deficiency other diagnostic studies: Difference between revisions
No edit summary |
Aditya Ganti (talk | contribs) |
||
| (13 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{21-hydroxylase deficiency}} | ||
{{CMG}} {{AE}} {{ | {{CMG}}; {{AE}} {{MJ}} | ||
==Overview== | ==Overview== | ||
Prenatal diagnosis for 21-hydroxylase deficiency may be used in diagnosis of [[congenital adrenal hyperplasia]]. Different tests which may be used are [[amniotic fluid]] testing and [[oligonucleotide]] hybridization of [[deoxyribonucleic acid]] (DNA) obtained from [[Chorionic villus sampling|chorionic villus samples]], and utilization of [[fetal]] [[DNA]] extracted from [[maternal]] [[blood]] through non-invasive methods. | |||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Prenatal diagnosis for 21-hydroxylase deficiency may be used in diagnosis of [[congenital adrenal hyperplasia]]. Different tests which may be used are: | |||
* [[Amniotic fluid]] testing and [[oligonucleotide]] hybridization of [[deoxyribonucleic acid]] ([[DNA]]) obtained from [[Chorionic villus sampling|chorionic villus samples]]. | |||
* Utilize [[fetal]] [[DNA]] extracted from [[maternal]] [[blood]] through non-invasive methods.<ref name="pmid27378492">{{cite journal |vauthors=Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T |title=New developments in prenatal diagnosis of congenital adrenal hyperplasia |journal=J. Steroid Biochem. Mol. Biol. |volume=165 |issue=Pt A |pages=121–123 |year=2017 |pmid=27378492 |doi=10.1016/j.jsbmb.2016.06.016 |url=}}</ref> | |||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{ | {{WH}} | ||
{{ | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
| Line 15: | Line 18: | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Intersexuality]] | [[Category:Intersexuality]] | ||
[[Category:Medicine]] | |||
[[Category: Up-To-Date]] | |||
Latest revision as of 15:32, 24 July 2020
|
21-hydroxylase deficiency Microchapters |
|
Differentiating 21-Hydroxylase Deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency other diagnostic studies |
|
21-hydroxylase deficiency other diagnostic studies in the news |
|
Risk calculators and risk factors for 21-hydroxylase deficiency other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Prenatal diagnosis for 21-hydroxylase deficiency may be used in diagnosis of congenital adrenal hyperplasia. Different tests which may be used are amniotic fluid testing and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus samples, and utilization of fetal DNA extracted from maternal blood through non-invasive methods.
Other Diagnostic Studies
Prenatal diagnosis for 21-hydroxylase deficiency may be used in diagnosis of congenital adrenal hyperplasia. Different tests which may be used are:
- Amniotic fluid testing and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus samples.
- Utilize fetal DNA extracted from maternal blood through non-invasive methods.[1]
References
- ↑ Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T (2017). "New developments in prenatal diagnosis of congenital adrenal hyperplasia". J. Steroid Biochem. Mol. Biol. 165 (Pt A): 121–123. doi:10.1016/j.jsbmb.2016.06.016. PMID 27378492.